Evaluating Metabolic and Anti-inflammatory Effect of Genistein on Post-myocardial Infarction Patients
Recruiting
N/A
Interventional Study
Myocardial Infarction (MI)
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 73 (estimated)
- Sponsor
- National Taiwan University Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to learn if genistein works to provide a beneficial effect to show lipid lowering effect and anti-inflammatory effects and slow the progression of atherosclerosis in post-myocardial infarction adults. It will also learn about the safety of genistein. The main questions it aims to answer are:
Does genistein lower triglyceride in participants? What medical problem…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion criteria
1. Written informed consent.
2. Age ≥ 18 years.
3. History of spontaneous myocardial infarction at least 28 days before recruitment.
4. hsCRP ≥ 0.1 mg/dL
5. BMI ≥ 27
Exclusion criteria
1. Pregnant or nursing (lactating) women
2. Women of child-bearing potential
3. Planned coron…
Contacts